Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
22.75
-1.19 (-4.97%)
BSENSE

Dec 23

BSE+NSE Vol: 9.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Dec'16
Net Sales
150.07
176.15
822.47
822.98
967.10
904.83
1,025.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
2.69
Total Operating income
150.07
176.15
822.47
822.98
967.10
904.83
1,027.91
Raw Material Cost
87.24
116.49
344.54
364.31
401.03
367.05
448.93
Purchase of Finished goods
0.74
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
1.51
-0.71
-6.91
14.96
-19.44
6.01
-17.36
Employee Cost
23.85
26.54
184.74
160.02
166.08
139.47
141.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.01
0.00
188.08
209.55
226.61
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
59.73
40.82
259.96
254.91
75.58
4.78
0.00
Total Expenditure (Excl Depreciation)
173.08
183.13
782.34
794.20
811.34
726.86
799.84
Operating Profit (PBDIT) excl Other Income
-23.01
-6.98
40.13
28.78
155.76
177.97
228.08
Other Income
0.28
0.70
8.04
5.84
17.09
6.39
3.08
Operating Profit (PBDIT)
-22.73
-6.28
48.17
34.62
172.85
184.36
231.16
Interest
27.39
29.70
44.67
44.17
54.43
62.77
47.49
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-50.12
-35.98
3.50
-9.55
118.42
121.59
183.67
Depreciation
12.49
13.33
51.37
49.47
50.74
42.58
46.25
Profit Before Tax
-62.60
-49.31
-47.87
-59.03
67.68
79.01
137.41
Tax
-0.05
0.00
2.47
-10.76
10.11
12.12
30.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-62.54
-49.31
-50.33
-48.27
57.57
66.89
106.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-62.54
-49.31
-50.33
-48.27
57.57
66.89
106.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-62.54
-49.31
-50.33
-48.27
57.57
66.89
106.42
Equity Capital
16.58
16.58
16.58
16.58
16.50
16.51
16.20
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
669.69
Diluted Earnings per share
-0.21
-2.77
-5.8
-3.75
1.26
2.5
6.19
Operating Profit Margin (Excl OI)
-15.33%
-3.96%
4.88%
3.5%
16.11%
19.67%
22.19%
Gross Profit Margin
-33.4%
-20.43%
0.43%
-1.16%
12.25%
13.44%
17.87%
PAT Margin
-41.67%
-27.99%
-6.12%
-5.87%
5.95%
7.39%
10.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2022 is -14.81% vs -78.58% in Dec 2021

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2022 is -26.83% vs 2.03% in Dec 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2022 is -229.66% vs -117.39% in Dec 2021

stock-summary

Interest

YoY Growth in nine months ended Dec 2022 is -7.78% vs -33.51% in Dec 2021

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2022 has fallen from Dec 2021

Compare Nine Monthly Results Of Vivimed Labs. With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
150.07
0
150.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
150.07
0
150.07
Raw Material Cost
87.24
0
87.24
Purchase of Finished goods
0.74
0
0.74
(Increase) / Decrease In Stocks
1.51
0
1.51
Employee Cost
23.85
0
23.85
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
59.73
0.00
59.73
Total Expenditure (Excl Depreciation)
173.08
0
173.08
Operating Profit (PBDIT) excl Other Income
-23.01
0.00
-23.01
Other Income
0.28
0
0.28
Operating Profit (PBDIT)
-22.73
0
-22.73
Interest
27.39
0
27.39
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
-50.12
0
-50.12
Depreciation
12.49
0
12.49
Profit Before Tax
-62.60
0
-62.60
Tax
-0.05
0
-0.05
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-62.54
0
-62.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-62.54
0
-62.54
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-62.54
0
-62.54
Equity Capital
16.58
0
16.58
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
-33.40%
0.00%
0.00
-33.40%
PAT Margin
-41.67%
0.00%
0.00
-41.67%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 150.07 Cr
in Dec 2022

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2022 is -14.81% vs -78.58% in Dec 2021

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -62.54 Cr
in Dec 2022

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2022 is -26.83% vs 2.03% in Dec 2021

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -23.01 Cr
in Dec 2022

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2022 is -229.66% vs -117.39% in Dec 2021

Nine Monthly - Interest
Interest 27.39 Cr
in Dec 2022

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2022 is -7.78% vs -33.51% in Dec 2021

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -15.33%
in Dec 2022

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2022 has fallen from Dec 2021